Corp-Ethics Home
Log In | Register New User
Home Company Search Related Articles Forum (new!)

Company GlaxoSmithKline [Company Info]
  Track this Company (an email will be sent to you everytime a report is filed about this company)

Date Issue Title
22nd Sep 2004 Questionable Practice Glaxo drops appeal in Aids drug pricing case

A landmark legal complaint against British drug maker GlaxoSmithKline (GSK) over its Aids drug pricing and policies in South Africa will proceed after GSK dropped its public and repeated vows to appeal a decision allowing the case to go forward, according to AidsHealthcare Foundation (AHF).

Instead, GSK simply filed a required legal response to the complaint, AHF said.

The complaint was filed with South Africa's Competition Tribunal in August by AHF, the US' largest Aids organisation and several other South African Aids advocates.
AHF operates the 'Ithembalabantu' (Zulu for people's hope) clinic, a free Aids treatment clinic in Umlazi Township, KwaZulu Natal in partnership with the Network of Aids Communities of South Africa (NetCom SA) a local non-government organisation.

In the complaint, AHF and others allege that GSK has charged excessive prices for Aids drugs to the detriment of South Africans with HIV/Aids and in violation of the Competition Act.

The complaint was originally filed with the Competition Commission in January 2003.

The Treatment Action Campaign (TAC) had lodged a similar complaint with the Competition Commission against GSK during 2002.

The Competition Commission initially decided to refer that complaint, as well as the AHF complaint, to the Competition Tribunal. During December 2003, TAC and GSK concluded a settlement endorsed by the Competition Commission.

However, AHF was not a party to that settlement.

Earlier this year, the Competition Tribunal of South Africa agreed to hear the complaint, which was filed by individual South Africans and AHF.

The Tribunal also ordered GSK to pay AHF's legal costs.

Other Reports on GlaxoSmithKline
Date Issue Company Report
29th Jan 2007 Questionable Practice GlaxoSmithKline GSK hid paxil suicide link
10th Aug 2006 Other Issue GlaxoSmithKline Glaxo pays $70m to end price row
29th Mar 2006 Questionable Practice GlaxoSmithKline Glaxo agrees US Paxil settlement
18th Mar 2005 Other Issue GlaxoSmithKline Glaxo shares dip on factory probe
6th Sep 2004 Other Issue GlaxoSmithKline GSK faces anti-depressant lawsuit
19th May 2004 Other Issue GlaxoSmithKline New York sues GlaxoSmithKline
11th May 2004 Fraud Investigation GlaxoSmithKline GlaxoSmithKline faces antitrust investigation
22nd Jan 2004 Fraud Investigation GlaxoSmithKline $11.1 Million settlement
8th Jan 2004 Questionable Practice GlaxoSmithKline 1.5bn Tax Bill
16th Dec 2003 Questionable Practice GlaxoSmithKline Glaxo's CEO to scoop 5.7 mln stg a year
25th Jun 2003 Questionable Practice GlaxoSmithKline FDA tells Glaxo to pull misleading Flonase ads
25th Jun 2003 Questionable Practice GlaxoSmithKline Ordered to pull misleading adverts

Related Reports from the Pharamaceutical Industry
Company Issue Report
Bristol-Myers Squibb Questionable Practice Bristol-Myers in $300m settlement
Pfizer Questionable Practice Pfizer to use DART for online campaigns
Pfizer Questionable Practice Pfizer claims Britons denied treatment
AstraZeneca Fraud Investigation $355m fraud fine
Pfizer Questionable Practice State Tax Report
Contact Us | Terms of Service | Privacy Policy | Add Report | Links
© 2006 | Corporate Ethics